Paulson & CO. Inc. Acquires New Position in HCA Holdings, Inc. (HCA)

Paulson & CO. Inc. acquired a new stake in shares of HCA Holdings, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 111,600 shares of the company’s stock, valued at approximately $8,261,000.

A number of other hedge funds have also recently made changes to their positions in HCA. Seven Eight Capital LP purchased a new stake in shares of HCA Holdings during the fourth quarter valued at approximately $273,000. Chieftain Capital Management Inc. purchased a new stake in shares of HCA Holdings during the fourth quarter valued at approximately $141,796,000. Tudor Investment Corp Et Al purchased a new stake in shares of HCA Holdings during the fourth quarter valued at approximately $518,000. GLG LLC purchased a new stake in shares of HCA Holdings during the fourth quarter valued at approximately $1,581,000. Finally, Orbimed Advisors LLC increased its stake in shares of HCA Holdings by 52.6% in the fourth quarter. Orbimed Advisors LLC now owns 2,002,200 shares of the company’s stock valued at $148,203,000 after buying an additional 690,000 shares during the period. 72.27% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for HCA Holdings (NYSE:HCA)

HCA Holdings, Inc. (NYSE:HCA) traded up 0.72% during midday trading on Friday, reaching $87.07. 1,856,977 shares of the company’s stock were exchanged. The firm’s 50 day moving average is $81.46 and its 200 day moving average is $76.76. The firm has a market capitalization of $32.26 billion, a price-to-earnings ratio of 11.93 and a beta of 0.71. HCA Holdings, Inc. has a 52 week low of $66.03 and a 52 week high of $87.44.

HCA Holdings (NYSE:HCA) last issued its earnings results on Tuesday, January 31st. The company reported $1.89 EPS for the quarter, beating the Zacks’ consensus estimate of $1.79 by $0.10. The firm had revenue of $10.64 billion for the quarter, compared to analyst estimates of $10.67 billion. HCA Holdings had a negative return on equity of 44.79% and a net margin of 6.84%. HCA Holdings’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.69 earnings per share. On average, equities analysts anticipate that HCA Holdings, Inc. will post $7.35 earnings per share for the current year.

This piece of content was first published by Zolmax and is the property of of Zolmax. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The original version of this piece of content can be read at https://zolmax.com/investing/sec-filing-articles/paulson-co-inc-acquires-new-position-in-hca-holdings-inc-hca-2/1220627.html.

Several brokerages recently commented on HCA. Zacks Investment Research raised shares of HCA Holdings from a “hold” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Friday, February 3rd. RBC Capital Markets reissued an “outperform” rating and set a $98.00 price objective (up from $95.00) on shares of HCA Holdings in a research report on Wednesday, February 1st. Royal Bank of Canada increased their price objective on shares of HCA Holdings from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Wednesday, February 1st. Evercore ISI increased their price objective on shares of HCA Holdings to $88.00 and gave the company a “buy” rating in a research report on Tuesday, January 31st. Finally, Avondale Partners raised shares of HCA Holdings from a “market perform” rating to an “outperform” rating and set a $96.00 price objective on the stock in a research report on Tuesday, January 17th. Five investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $89.12.

In related news, insider Michael S. Cuffe sold 4,300 shares of the company’s stock in a transaction that occurred on Monday, January 9th. The stock was sold at an average price of $78.00, for a total value of $335,400.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Charles J. Hall sold 100,000 shares of the company’s stock in a transaction that occurred on Friday, February 3rd. The shares were sold at an average price of $83.79, for a total value of $8,379,000.00. Following the completion of the sale, the insider now owns 76,969 shares in the company, valued at approximately $6,449,232.51. The disclosure for this sale can be found here. In the last quarter, insiders sold 245,888 shares of company stock worth $20,379,533. 3.10% of the stock is owned by insiders.

About HCA Holdings

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).